4.5 Article

Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats

期刊

ACTA DIABETOLOGICA
卷 51, 期 4, 页码 553-558

出版社

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s00592-013-0550-2

关键词

Zucker diabetic fatty rats; Diabetic retinopathy; Preclinical model; Growth factors; Inflammation; Adhesion

资金

  1. Sanofi

向作者/读者索取更多资源

Obese Zucker diabetic fatty (ZDF) rats are used as a type-2 diabetes model for microvascular complications. In order to study retinopathy in this model, changes in retinal vasculature were analyzed by quantitative morphometry and related to retinal expression of 46 selected genes that were analyzed by microfluidic card PCR technology. At 3 months of age, obese animals had developed stable hyperglycemia (20.7 +/- A 1.3 mmol/L plasma glucose vs. 6.5 +/- A 0.1 mmol/L in lean). Hyperinsulinemia initially presented in obese rats at 2 months (10.5 +/- A 0.7 mu g/L plasma insulin vs. 0.2 +/- A 0.04 mu g/L in lean) and decreased at 3 months (3.9 +/- A 0.6 vs. 0.5 +/- A 0.09 mu g/ml in lean). At 8 months of age, animals had developed microvascular complications. An increased number of acellular capillaries in obese (24 +/- A 5/mm(2)) versus lean (15 +/- A 4/mm(2)) and a decreased number of retinal pericytes in obese (2,270 +/- A 250/mm(2)) versus lean animals (1,620 +/- A 243/mm(2)) could be observed. VEGFa, MIF, and HIF-1 alpha were the most abundantly expressed and inflammatory genes such as TNF alpha and IL-6 are the least abundantly expressed genes. None of these genes were differentially regulated. Surprisingly, specific growth factors such as bFGF (FGF2) and placental growth factor, and adhesion molecules such as ICAM-1 were abundantly expressed and up-regulated in diabetic versus non-diabetic ZDF rats. In summary, we observed in type-2 diabetic ZDF rats retinopathy with retinal vasoregression along with a simultaneous up-regulation of specific growth factors such as bFGF and adhesion molecules, but only minor changes in key inflammatory genes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy

Tamara R. Castaneda, Maria Mendez, Ian Davison, Ralf Elvert, Uwe Schwahn, Galina Boldina, Corinne Rocher, Petra Scherer, Kuldeep Singh, Dinesh S. Bangari, Mechthilde Falkenhahn, Aimo Kannt, Anish Konkar, Philip J. Larsen, Cynthia Arbeeny, Pradeep K. Dhal, Thomas Huebschle

Summary: The novel nonabsorbed polymeric sequestrant SAR442357, possessing optimized phosphate and bile salt sequestration characteristics, demonstrated pharmacological benefits including improved glycemic control, lowered serum cholesterol, and attenuation of diabetic kidney disease progression.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)

Article Pharmacology & Pharmacy

Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis

Aimo Kannt, Paulus Wohlfart, Andreas Nygaard Madsen, Sanne Skovgard Veidal, Michael Feigh, Dieter Schmoll

Summary: The study demonstrated that treatment with resmetirom in DIO-NASH mice significantly improved hepatic metabolism and fibrosis levels, reflecting the benefits of THR-beta activation.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Food Science & Technology

Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial

Charalampia Amerikanou, Stavroula Kanoni, Andriana C. Kaliora, Angela Barone, Mladen Bjelan, Giuseppe D'Auria, Aristea Gioxari, Maria Jose Gosalbes, Sofia Mouchti, Maria G. Stathopoulou, Beatriz Soriano, Stefan Stojanoski, Rajarshi Banerjee, Maria Halabalaki, Eleni V. Mikropoulou, Aimo Kannt, John Lamont, Carlos Llorens, Fernando Marascio, Miriam Marascio, Francisco J. Roig, Ilias Smyrnioudis, Iraklis Varlamis, Sophie Visvikis-Siest, Milan Vukic, Natasa Milic, Milica Medic-Stojanoska, Lucia Cesarini, Jonica Campolo, Amalia Gastaldelli, Panos Deloukas, Maria Giovanna Trivella, M. Pilar Francino, George V. Dedoussis

Summary: Mastiha supplementation improves microbiota dysbiosis and lipid metabolite levels in patients with NAFLD, particularly reducing liver inflammation/fibrosis parameters in severely obese patients.

MOLECULAR NUTRITION & FOOD RESEARCH (2021)

Article Biochemistry & Molecular Biology

Novel Inhibitors of Nicotinamide-N-Methyltransferase for the Treatment of Metabolic Disorders

Aimo Kannt, Sridharan Rajagopal, Mahanandeesha S. Hallur, Indu Swamy, Rajendra Kristam, Saravanakumar Dhakshinamoorthy, Joerg Czech, Gernot Zech, Herman Schreuder, Sven Ruf

Summary: Nicotinamide-N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosyl-methionine (SAM) to nicotinamide (Nam). Its expression in various tissues has been linked to metabolic diseases, and potent small molecule inhibitors with different binding modes have been identified through X-ray crystallographic studies.

MOLECULES (2021)

Article Physiology

Microglial Activation Is Associated With Vasoprotection in a Rat Model of Inflammatory Retinal Vasoregression

Sarah Riemann, Matthias Kolibabka, Stephanie Busch, Jihong Lin, Sigrid Hoffmann, Norbert Gretz, Yuxi Feng, Paulus Wohlfart, Hans-Peter Hammes

Summary: Vascular dysfunction and vasoregression are characteristics of various inflammatory central nervous system disorders and inflammation-related retinal diseases. Activation of microglia and the humoral innate immune system play contributing roles. In this study, clodronate treatment led to an increase in activated CD74(+) microglia and prevented acellular capillaries and pericyte loss, indicating a shift towards induction of pleiotropic protective pathways supporting vasoprotection in neurovascular retinal diseases.

FRONTIERS IN PHYSIOLOGY (2021)

Article Endocrinology & Metabolism

pdx1 Knockout Leads to a Diabetic Nephropathy- Like Phenotype in Zebrafish and Identifies Phosphatidylethanolamine as Metabolite Promoting Early Diabetic Kidney Damage

Lucas M. Wiggenhauser, Lena Metzger, Katrin Bennewitz, Silas Soleymani, Mike Boger, Christoph T. Tabler, Ingrid Hausser, Carsten Sticht, Paulus Wohlfart, Nadine Volk, Elena Heidenreich, Michael Buettner, Hans-Peter Hammes, Jens Kroll

Summary: This study identified the pdx1 mutant as a novel model for the study of DKD, showing signs of the early disease progression already in the larval stage and several selective features of later DKD in adult mutants.

DIABETES (2022)

Article Biochemistry & Molecular Biology

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection

Natasja de Bruin, Ann-Kathrin Schneider, Philipp Reus, Sonja Talmon, Sandra Ciesek, Denisa Bojkova, Jindrich Cinatl, Imran Lodhi, Bruce Charlesworth, Simon Sinclair, Graham Pennick, William F. Laughey, Philip Gribbon, Aimo Kannt, Susanne Schiffmann

Summary: The study found that ibuprofen, flurbiprofen, etoricoxib, and paracetamol have no effect on ACE2 expression and activity in vitro or in vivo. However, high concentrations of ibuprofen and flurbiprofen can reduce the replication of SARS-CoV-2.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biophysics

Concentration-dependent effects of dichloroacetate in type 2 diabetic hearts assessed by hyperpolarized [1-13C]-pyruvate magnetic resonance imaging

Esben Sovso Szocska Hansen, Lotte Bonde Bertelsen, Nikolaj Bogh, Jack Miller, Paulus Wohlfart, Steffen Ringgaard, Christoffer Laustsen

Summary: Personalized medicine or individualized therapy has great significance in complex diseases like diabetes. This study demonstrates the potential of using hyperpolarized [1-C-13]-pyruvate magnetic resonance imaging to differentiate treatment effects, enabling personalized therapy.

NMR IN BIOMEDICINE (2022)

Article Cell & Tissue Engineering

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS route for SARS-CoV-2

Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, Marcel S. Woo, Fabian Heinrich, Michaela Schweizer, Antje Appelt-Menzel, Alevtina Cubukova, Janica Barenberg, Jennifer Leu, Kristin Hartmann, Edda Thies, Jessica Lisa Littau, Diego Sepulveda-Falla, Liang Zhang, Kathy Ton, Yan Liang, Jakob Matschke, Franz Ricklefs, Thomas Sauvigny, Jan Sperhake, Antonia Fitzek, Anna Gerhartl, Andreas Brachner, Nina Geiger, Eva-Maria Koenig, Jochen Bodem, Soren Franzenburg, Andre Franke, Stefan Moese, Franz-Josef Mueller, Gerd Geisslinger, Carsten Claussen, Aimo Kannt, Andrea Zaliani, Philip Gribbon, Benjamin Ondruschka, Winfried Neuhaus, Manuel A. Friese, Markus Glatzel, Ole Pless

Summary: Neurological complications are common in COVID-19. This study reveals that SARS-CoV-2 can enter the brain through the blood-brain barrier and cause increased interferon signaling. In vitro experiments show that SARS-CoV-2 can infect BCECs and replicate, with the virus being transported across the barrier. This process can be inhibited by specific antibodies or inhibitors.

STEM CELL REPORTS (2022)

Article Chemistry, Organic

Antidiabetic profiling of veramycins, polyketides accessible by biosynthesis, chemical synthesis and precursor-directed modification

Denis Dardic, Nils Bohringer, Alberto Plaza, Florian Zubeil, Juliane Pohl, Svenja Sommer, Leo Padva, Jonathan Becker, Maria A. Patras, Mona-Katharina Bill, Michael Kurz, Luigi Toti, Sven W. Gorgens, Soren M. M. Schuler, Andre Billion, Oliver Schwengers, Paulus Wohlfart, Alexander Goesmann, Norbert Tennagels, Andreas Vilcinskas, Peter E. Hammann, Till F. Schaberle, Armin Bauer

Summary: Seven new polyketides, called veramycins, were isolated from a Streptomyces sp. and shown to increase glucose uptake and insulin sensitivity in rat skeletal muscle cells. The syntheses of these compounds were successfully achieved, enabling further exploration of their potential as anti-diabetic lead structures. The biosynthetic pathway for veramycin A was also proposed based on feeding experiments and gene inactivation.

ORGANIC CHEMISTRY FRONTIERS (2022)

Article Pharmacology & Pharmacy

Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort

Jiedong Qiu, Benito A. Yard, Bernhard K. Kraemer, Harry van Goor, Peter van Dijk, Aimo Kannt

Summary: CN1 concentration and activity are associated with the prediction and diagnosis of diabetic kidney disease, but further research is needed for validation.

FRONTIERS IN PHARMACOLOGY (2022)

Article Physiology

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement

Zeynep E. Yesilyurt, Jan Matthes, Edith Hintermann, Tamara R. Castaneda, Ralf Elvert, Jesus H. Beltran-Ornelas, Diana L. Silva-Velasco, Ning Xia, Aimo Kannt, Urs Christen, David Centurion, Huige Li, Andrea Pautz, Ebru Arioglu-Inan, Martin C. Michel

Summary: This study explores the relationship between bladder enlargement and diabetes in rodent models, finding significant variations in bladder enlargement across different models, particularly in type 2 diabetes models. The study concludes that bladder enlargement is not primarily driven by glucose levels.

FRONTIERS IN PHYSIOLOGY (2022)

Article Multidisciplinary Sciences

Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders

Sven Ruf, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur, Mahanandeesha S. Hallur, Shilpa Rani, Rajendra Kristam, Srinivasan Swaminathan, Bharat Ravindra Zope, Pavan Kumar Gondrala, Indu Swamy, V. P. Rama Kishore Putta, Saravanan Kandan, Gernot Zech, Herman Schreuder, Christine Rudolph, Ralf Elvert, Joerg Czech, Swarnakumari Birudukota, M. Amir Siddiqui, Niranjan Naranapura Anand, Vishal Subhash Mane, Sreekanth Dittakavi, Juluri Suresh, Ramachandraiah Gosu, Mullangi Ramesh, Takeshi Yura, Saravanakumar Dhakshinamoorthy, Aimo Kannt

Summary: NNMT is a metabolic regulator associated with various diseases. A potential NNMT small molecule inhibitor, JBSNF-000028, was identified and shown to reduce MNA levels and improve insulin sensitization and weight reduction in mouse models. The findings suggest that JBSNF-000028 could be a potential therapeutic option for metabolic disorders.

SCIENTIFIC REPORTS (2022)

Article Environmental Sciences

Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study

Athina Amanatidou, Andriana C. Kaliora, Charalampia Amerikanou, Stefan Stojanoski, Natasa Milosevic, Chara Vezou, Mirjana Beribaka, Rajarshi Banerjee, Ioanna-Panagiota Kalafati, Ilias Smyrnioudis, Mary Jo Kurth, Aimo Kannt, M. Pilar Francino, Sophie Visvikis-Siest, Panos Deloukas, Carlos Llorens, Fernando Marascio, Natasa Milic, Milica Medic-Stojanoska, Amalia Gastaldelli, Maria Giovanna Trivella, George Dedoussis

Summary: This study investigated the association between dietary patterns and MRI parameters in European NAFLD patients. The results showed a positive correlation between the Western dietary pattern and the severity of liver disease, while the Low-Fat Dairy and Poultry dietary pattern was associated with lower liver disease values. These findings emphasize the importance of diet in NAFLD.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

暂无数据